September 19, 2008 - Boston Scientific Corp. announced this week a decision by the U.S. District Court in Delaware involving a case patent owned by Johnson & Johnson and Boston Scientific's NIR stent product.
In the decision, the Judge granted Johnson & Johnson's motion for entry of final judgment and denied Boston Scientific's motion for a new trial.
In 2000, a jury awarded Johnson & Johnson $324 million in damages based on Boston Scientific's sale of the NIR stent. The Court also awarded pre-judgment interest at prime rate based on after-tax damages.

September 19, 2008 – Last month, MIV announced continued positive results for VESTAsync, a polymer-free drug-eluting stent, at a twelve-month clinical follow-up for fifteen patients in its first-in-man VESTASYNC I Trial, reporting that all patients remain free of any major adverse cardiac events or MACE.
MIV also announced that it now has accumulated nine-month intravascular ultrasound (IVUS) and Quantitative Coronary Angiography (QCA) for these same patients. This data showed no statistical difference from the safety and efficacy data reported at four months.

September 19, 2008 - The Larry King Cardiac Foundation and Rush University Medical Center, Chicago, have partnered to provide life-saving cardiac care for patients who have no insurance or limited means, bringing critical care to people who have no other options.
Rush cardiologists and heart surgeons will donate their time and perform surgeries at no cost to the patient, while the Foundation provides funding to compensate the hospital for the materials used.

September 19, 2008 - The 21st annual International Symposium on Endovascular Therapy (ISET) will be held Jan. 18-22, 2009, bringing together industry leaders and experts to deliver cutting-edge interventional education to meet the needs of physicians who recognize the challenges that lie ahead and actively seek the knowledge to meet those challenges.

September 19, 2008 - The Sudden Cardiac Arrest Association (SCAA) yesterday announced the recipients of its 2008 Leadership Awards in recognition of their significant contributions to sudden cardiac arrest awareness and prevention.

The honorees will receive their awards at the SCAA Awards Dinner, Oct. 18 in Philadelphia, held during the SCAA’s annual meeting, as part of a series of events in honor of National Sudden Cardiac Arrest Awareness Month.

September 17, 2008 - Micrus Endovascular Corp. yesterday initiated its worldwide launch of Neuropath guide catheter line, designed with a highly flexible and visible tip so neurointerventionalists can gain better vessel access and greater vessel selection in treating patients with complex anatomies.

September 17, 2008 - Syntermed Inc. said this week it debuted the company’s SyncTool, a diagnostic tool for heart failure, on GE Healthcare Xeleris 2 workstation at the American Society of Nuclear Cardiology (ASNC) meeting.

GE Healthcare exclusively licensed the software for new Xeleris workstations in conjunction with Syntermed’s Emory Cardiac Toolbox (ECTb) and is offering it as an upgrade to existing customers. SyncTool, a phase analysis software, analyzes the benefits of cardiac resynchronization therapy (CRT) in heart failure patients.

September 17, 2008 - Medtronic Inc. said this week it started two new trials of the Endeavor Resolute drug-eluting stent (DES), the company’s complement to the Endeavor drug-eluting stent, which was approved by the FDA in February.

September 17, 2008 - BioControl Medical said six month data for eight of the more than 30 patients who participated in the overall European pilot study of CardioFit for Congestive Heart Failure was published in the European Journal of Heart Failure, volume 10, issue 9, pages 884–891.

September, 17, 2008 - The American College of Cardiology (ACC) yesterday launched its Quality First campaign that advocates for new standards for quality in healthcare reform, while setting forth initiatives to begin moving the American healthcare system immediately and dramatically forward.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now